frame  International Workshop 2014 - Rauischholzhausen frame
frame frame frame
frame frame Marburg, 21. Sep. 2017 frame
frame Announcement
frame Program
frame Location
frame Accommodation
frame Application
frame Contact
frame Practical Information
frame Sponsors
frame Archive
frame AG Klebe

frame frame


Workshop "The Aspect of Time in Drug Design"

(last update: April 8th, 2014)

Click to download in original size (7 MB)

Monday, March 24, 2014

15:00 Opening and Introduction (Klebe)

15:15 Paul Leeson, GlaxoSmithKline, Stevenage, United Kingdom
Understanding compound quality

16:00 Jonathan Essex, Univ. of Southampton, United Kingdom
The role of water structure in protein-ligand binding thermody

16:45 Coffee

17:15 Bert de Groot, MPI Göttingen, Germany
Quantitative affinity prediction from first principles

18:00 Stefan Krimmer, Univ. Marburg, Germany
Influence of water molecules on protein-ligand binding: Correlation of structure and thermodynamic signature [pdf]

19:00 Dinner

20:00 Poster Session

Tuesday, March 25, 2014

9:00 Christian Griesinger, MPI Göttingen, Germany
Structure and dynamics in drug-target interactions investigated by NMR spectroscopy

9:45 Anthony Watts, Univ. Oxford, United Kingdom
Conformational dynamics of ligands at their target site in membranes - implications for drug design

10:30 Coffee

11:00 Ilme Schlichting, MPI Heidelberg, Germany
Recent developments in time-resolved crystallography [pdf]

11:45 Anna Hirsch, Univ. of Groningen, Netherlands
Structure-Based Design of Novel Inhibitors for the Aspartic Protease Endothiapepsin Exploiting Dynamic Combinatorial Chemistry

13:00 Lunch

15:00 Klaus Gerwert, Univ. Bochum, Germany
IR spectroscopy to study protein dynamics, proton transfer via protein-bound water

15:45 Andreas Winkler, MPI Heidelberg, Germany
Analysis of structural dynamics by H/D-exchange coupled to mass spectrometry [pdf]

16:30 Coffee

17:00 Gert Vriend, Univ. Nijmegen, Netherlands
GPCRs from 10 BC till 13 AD [ppt, mp4]

17:45 Andreas Plückthun, Univ. Zürich, Switzerland
Evolving stable GPCRs for drug screening and structural analysis

19:00 Dinner

20:00 Musical Intermezzo

Wednesday, March 26, 2014

9:00 David Swinney, Inst. Rare and Neglected Diseases, San Francisco, USA
The contribution of binding kinetics to the therapeutic effectiveness of Medicines

9:45 Markku Hämäläinen, GE Healthcare Bio-Sciences AB, Uppsala, Sweden
The importance of recognition and residence time of drug-target interactions in understanding drug efficacy and SAR [pdf]

10:30 Coffee

11:00 Johannes Schiebel, Univ. Marburg, Germany
Why similar ligands can exhibit very different binding kinetics

11:45 Wolfgang Haap, Roche, Basel, Switzerland
The impact of binding kinetics on compound safety and efficacy - Case studies: Factor Xa and Cathepsin S inhibitors

13:00 Lunch

15:00 Peter Tonge, State Univ. of New York, Stony Brook, USA
Using drug-target residence time to assess target vulnerability and to improve in vivo drug activity

15:45 Gisela Schnapp, Boehringer-Ingelheim, Biberach, Germany
Analysis of binding kinetics of DPPIV Inhibitors and its relationship to structure

16:30 Coffee

17:00 Gianni De Fabritiis, Universitat Pompeu Fabra,Barcelona, Spain
In-silico ligand binding assays: poses, affinities and kinetics

17:45 Andrea Cavalli, Univ. Bologna and Italian Institute of Technology, Italy
The full binding mechanism of a transition state analogue to purine nucleoside phosphorylase via molecular dynamics and machine learning [pdf]

19:00 Dinner

Then Round-table discussion

Thursday, March 26, 2014

9:00 Matthias Frech, Merck-Serono, Darmstadt, Germany
Biophysics To Drive Lead Discovery: Getting into kinetics and use it

9:45 Albert Pan, D.E. Shaw Research, New York, USA
Drug binding and subtype selectivity in G-protein-coupled receptors [pdf]

10:30 Coffee

11:00 Klaus Liedl, Univ. Innsbruck, Austria
Does Flexibility Control the Specificity of Protein-Protein and Protein-Drug Interfaces? [pdf]

11:45 Manfred Reetz, Univ. Marburg, Germany
Recent Developments in Directed Evolution of Stereoselective Enzymes

13:00 Lunch

14:00 End of Workshop

frame frame frame